Affixus
Payments companies reported to CMS as associated with Affixus. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Affixus, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Affixus
These are the largest totals companies reported as associated with Affixus. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| George Haidukewych | Orlando, FL | Orthopaedic Surgery | $587,568.32 |
| Cory Collinge | Fort Worth, TX | Orthopaedic Trauma | $490,650.97 |
| Frank Liporace | Jersey City, NJ | Orthopaedic Trauma | $468,683.47 |
| Brian Mullis | Indianapolis, IN | Orthopaedic Surgery | $283,719.03 |
| Michael Henley | Seattle, WA | Orthopaedic Trauma | $216,035.07 |
| Daniel Horwitz | Danville, PA | Orthopaedic Surgery | $109,578.55 |
| Stephen Sems | Rochester, MN | Orthopaedic Surgery | $101,873.66 |
| Ravi Karia | San Antonio, TX | Orthopaedic Surgery | $79,513.78 |
| Edward Westrick | Pittsburgh, PA | Orthopaedic Surgery | $42,484.53 |
| Myron Slobogean | Baltimore, MD | Orthopaedic Trauma | $28,690.25 |
Prescribed Affixus?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.